Código QR (código de barras bidimensional)

Infliximab versus ciclosporin in steroid resistant acute severe ulcerative colitis: a model-based cost-utility analysis of data from CONSTRUCT pragmatic trial

Abstract Background There is limited evidence in the literature on the long-term effectiveness and cost-effectiveness of treatments for Acute Severe Ulcerative Colitis (ASUC). The study aimed to perform decision analytic model-based long-term cost-utility analysis (CUA) of infliximab versus ciclospo...

ver descrição completa

Na minha lista:
Principais autores: Mohammed Fasihul Alam, Mirella Longo, David Cohen, Sam Groves, Laith Alrubaiy, Hayley A. Hutchings, Alan Watkins, Shaji Sebastain, John G. Williams
Formato: Artigo
Idioma:Inglês
Publicado em: BMC 2023-03-01
coleção:BMC Health Services Research
Assuntos:
Ulcerative colitis
Infliximab
Ciclosporin
Cost-effectiveness
Decision tree
Markov model
Acesso em linha:https://doi.org/10.1186/s12913-023-09233-w
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados